Serstech AB (DE:284)
FRANKFURT:284
Want to see DE:284 full AI Analyst Report?
284 Stock Chart & Stats
€0.04
<€0.01(1.85%)
At close: 4:00 PM EST
€0.04
<€0.01(1.85%)
Day’s Range― - ―
52-Week Range€0.01 - €0.07
Previous CloseN/A
Volume1.46K
Average Volume (3M)3.50K
Market Cap
€12.41M
Enterprise Value€134.00M
Total Cash (Recent Filing)€787.00K
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Jul 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding254,319,050
10 Day Avg. Volume500
30 Day Avg. Volume3,500
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.02
Price to Sales (P/S)3.75
P/FCF Ratio-5.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)€6.77M
Bulls Say, Bears Say
Bulls Say
Niche Product And Market FitSerstech’s focus on handheld Raman spectroscopy for field use targets durable needs in safety, security and industrial inspection. Portable chemical ID is a structural use case with high switching costs for specialized hardware and corpus of spectral libraries, supporting steady long-term demand.
Diversified Revenue Streams (hardware, Software, Services)The business generates sales from hardware, accompanying software and ongoing support/services. This product + software + service mix supports recurring revenue potential, customer lock‑in via spectral libraries, and upsell opportunities that improve revenue durability beyond one‑off device sales.
Very Low Leverage / No DebtZero reported debt across multiple years materially reduces refinancing and interest risks. With no leverage, the company retains financial flexibility to fund product development or absorb cyclical weakness, giving it time to execute turnarounds without immediate solvency pressure.
Bears Say
Revenue Decline And Loss-making MarginsA sharp multi-year revenue contraction paired with deeply negative margins indicates the core business is not currently profitable or scalable at present volumes. Sustained revenue shrinkage undermines operating leverage, compresses margins further and weakens the ability to invest in growth initiatives.
Negative Operating Cash Flow And Cash BurnConsistent negative operating and free cash flow implies the company is consuming cash to run operations and cannot self‑fund growth or cushion downturns. Persistent cash burn forces reliance on financing or equity raises, which can dilute shareholders and constrain long‑term strategic choices.
Erosion Of Equity BaseMaterial decline in equity over successive periods signals value destruction from cumulative losses. A shrinking equity base limits balance sheet resilience, increases vulnerability to adverse shocks, and reduces the buffer available to support investment or weather prolonged weak operating performance.
284 FAQ
What was Serstech AB’s price range in the past 12 months?
Serstech AB lowest stock price was €0.01 and its highest was €0.07 in the past 12 months.
What is Serstech AB’s market cap?
Serstech AB’s market cap is €12.41M.
When is Serstech AB’s upcoming earnings report date?
Serstech AB’s upcoming earnings report date is Jul 27, 2026 which is in 67 days.
How were Serstech AB’s earnings last quarter?
Serstech AB released its earnings results on Apr 24, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Serstech AB overvalued?
According to Wall Street analysts Serstech AB’s price is currently Overvalued.
Does Serstech AB pay dividends?
Serstech AB does not currently pay dividends.
What is Serstech AB’s EPS estimate?
Serstech AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Serstech AB have?
Serstech AB has 254,319,050 shares outstanding.
What happened to Serstech AB’s price movement after its last earnings report?
Serstech AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of Serstech AB?
Currently, no hedge funds are holding shares in DE:284
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Serstech AB
Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.
Technical Analysis
Nexam Chemical Holding AB
―
Arctic Minerals AB
―
aXichem AB Class A
―
XP Chemistries AB
―
Ferroamp AB
―